Error: Could not add to watchlist. X

Carnegie Fund II - Biotechnology Sub-Fund

+ Watchlist
CARBIOA:LX
39.06
EUR
As of 00:00:00 ET on 07/31/2015.
Fund Type
SICAV
52Wk Range
26.08 - 41.76
1 Yr Return
63.02%
YTD Return
24.75%
52Wk Range
26.08 - 41.76
1 Yr Return
63.02%
YTD Return
24.75%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/31/2015)
39.06
Total Assets (m EUR) (on 06/30/2015)
34.683
Inception Date
10/10/2000
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
ULF ARVIDSSON
Front Load Fee
-
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.10%
Expense Ratio
1.10%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 29.00 k 3.05 m 8.79
Celgene Corp 28.50 k 2.94 m 8.48
Biogen Inc 8.20 k 2.94 m 8.46
Vertex Pharmaceuticals Inc 22.65 k 2.51 m 7.23
BioMarin Pharmaceutical Inc 15.00 k 1.81 m 5.21
Regeneron Pharmaceuticals Inc 3.35 k 1.52 m 4.40
Mylan NV 24.00 k 1.45 m 4.19
Medivation Inc 13.80 k 1.38 m 3.99
Tetraphase Pharmaceuticals Inc 33.00 k 1.31 m 3.78
Cempra Inc 43.00 k 1.27 m 3.67
Profile
Carnegie Fund II - Biotechnology Sub-Fund is an open-end investment fund registered in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in equities of companies in the biotechnology/bioscience area including companies with activities in the areas of drug discovery & delivery, therapeutics, and enabling technologies with market cap less than 500 million.
ADDRESS
c/o Carnergie Fund Services SA
P.O. BOX 1141
L-1011 Luxembourg
Luxembourg
PHONE
352-40-40-30-1